Astellas adding ‘off-the-shelf’ stem cell tech in $102.5m acquisition – BioPharma-Reporter.com
BioPharma-Reporter.com |
Astellas adding ‘off-the-shelf’ stem cell tech in $102.5m acquisition
BioPharma-Reporter.com Once the deal is complete, the Seattle-based stem cell maker will become a subsidiary operating under Astellas’ Institute for Regenerative Medicine (AIRM), established in 2016. It will also grant Astellas direct access to Universal Cells’ universal … Global Stem Cells Banking Market — Revolutionary Way to Cure Life-Threatening Diseases through Stem Cell Banking …GlobeNewswire (press release) Stem Cell Therapy 2.0 – LI Practice Treats More Chronic ConditionsPR Newswire (press release) USRM Posts Live Webinar with World Renowned BiohackerMarkets Insider Facts of Week –The Financial all 26 news articles » |
The Nation |
SSO expands coverage for stem–cell treatments
The Nation The SSO now supports allogeneic stem–cell transplants from unrelated donors via the Thai Red Cross Society. Previously it covered only autologous transplants (those of patients’ own cells) or allogeneic treatments from related donors, such as siblings … |
